Down-regulation and Clinic-pathological Correlation of SIK-1 and SIK-1-LNC in Non-small Cell Lung Cancer Patients
Alireza AnvarniaReza PanahizadehHabib ZarredarMilad AsadiShahriyar HashemzadehMohammad Amin VatankhahHamed ValizadehMortaza RaeisiPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
Collectively, our study emphasized the role of SIK-1-LNC and SIK-1 downregulation in NSCLC oncogenesis. Additionally, SIK-1 and SIK-1-LNC, particularly the latter, have shown remarkable potential to be utilized as new NSCLC biomarkers and therapeutic targets.